Abstract
Uterine fibroids and adenomyosis are prevalent benign neoplasms that can lead to serious
deleterious health effects including life-threatening anemia, prolonged menses, and
pelvic pain; however, up to 40% of women remain undiagnosed. Traditional treatment
options such as myomectomy or hysterectomy can effectively manage symptoms but may
entail longer hospital stays and hinder future fertility. Endovascular treatment,
such as uterine artery embolization (UAE), is a minimally invasive procedure that
has emerged as a well-validated alternative to surgical options while preserving the
uterus and offering shorter hospital stays. Careful patient selection and appropriate
techniques are crucial to achieving optimal outcomes. There have been advancements
in recent times that encompass pre- and postprocedural care aimed at enhancing results
and alleviating discomfort prior to, during, and after UAE. Furthermore, success and
reintervention rates may also depend on the size and location of the fibroids. This
article reviews the current state of endovascular treatments of uterine fibroids and
adenomyosis.
Keywords
fibroid - adenomyosis - embolization - uterine artery embolization - interventional
radiology
